Skip to main content
Article thumbnail
Location of Repository

Use of 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Rare Head and Neck Cancers

By Jong-Lyel Roh, Byoung Jae Moon, Jae Seung Kim, Jeong Hyun Lee, Kyung-Ja Cho, Seung-Ho Choi, Soon Yuhl Nam, Bong-Jae Lee and Sang Yoon Kim
Topics: Original Article
Publisher: Korean Society of Otorhinolaryngology-Head and Neck Surgery
OAI identifier: oai:pubmedcentral.nih.gov:2671791
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2005). Adult head and neck soft tissue sarcomas. Head Neck.
    2. (2005). Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma. Curr Opin Oncol.
    3. (2007). Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med.
    4. (2008). Current use of 18F-fluorodeoxyglucose positron emission tomography and combined 108
    5. (2003). Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck. Invest Radiol.
    6. (2002). Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol.
    7. (2001). Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med.
    8. (2006). Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging.
    9. (2005). Head and neck melanoma. Cancer Control.
    10. (2000). Imaging-based nodal classification for evaluation of neck metastatic adenopathy.
    11. (2005). Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol.
    12. (2005). Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    13. (2003). Olfactory neuroblastoma: past, present, and future? Laryngoscope.
    14. (1976). Olfactory neuroblastoma. A clinical analysis of 17 cases.
    15. (2004). Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med.
    16. (2003). Positron emission tomography for basal cell carcinoma of the head and neck. Arch Dermatol.
    17. (2006). positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg.
    18. (2000). Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg.
    19. (2005). Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas. Ann Surg.
    20. (1998). Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med.
    21. (2006). Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Oral Oncol.
    22. (2001). Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.
    23. (2005). Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med.
    24. (2006). Utility of positron emission tomography in sarcomas. Curr Opin Oncol.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.